Cigna(US:CI) ZACKS·2025-10-30 14:35Core Insights - Cigna reported a revenue of $69.57 billion for the quarter ended September 2025, reflecting a year-over-year increase of 9.2% and surpassing the Zacks Consensus Estimate of $67.16 billion by 3.59% [1] - The company's EPS for the quarter was $7.83, an increase from $7.51 in the same quarter last year, also exceeding the consensus estimate of $7.70 by 1.69% [1] Financial Performance Metrics - Medical Care Ratio was reported at 84.8%, slightly above the average estimate of 84.2% [4] - Pharmacy claim volume reached 558 million, exceeding the average estimate of 546.6 million [4] - Total Medical Customers stood at 18.06 million, matching the average estimate [4] - Net investment income was $233 million, below the average estimate of $245.97 million but showing a significant year-over-year increase of 174.1% [4] - Pharmacy revenues were $56.05 billion, surpassing the average estimate of $53.14 billion with a year-over-year growth of 16.1% [4] - Premium revenues were reported at $9.08 billion, slightly above the average estimate of $9.03 billion, but reflecting a decline of 20.6% year-over-year [4] - Cigna Healthcare revenues were $10.93 billion, slightly below the average estimate of $10.95 billion, representing an 18% year-over-year decline [4] - Revenues from Evernorth Health Services were $60.39 billion, exceeding the average estimate of $57.17 billion with a year-over-year increase of 15.1% [4] - Fees and Other revenues were $4.38 billion, above the average estimate of $4.29 billion, showing a year-over-year increase of 12.6% [4] - U.S. Commercial Stop Loss premiums were $1.91 billion, slightly below the average estimate of $1.92 billion, but reflecting a year-over-year increase of 13% [4] Stock Performance - Cigna's shares have returned +2.6% over the past month, compared to the Zacks S&P 500 composite's +3.6% change, indicating a performance in line with the broader market [3]